Innovative sapphire dosing pumps for highly-accurate filling of liquid pharmaceuticals.

Such dosing pumps are being used in pharmaceutical, chemical, food, perfume and

other industries.

The Product is high-yielding and cost-effective.

About Product

PharmaSapphire

dosing pumps are highly resistant to wear and tear

increased chemical purity of liquid pharmaceuticals being dosed

increased efficiency of human medical products

2-3 times increased shelf life of pharmaceutical products

10 years of manufacturer warranty for the Product (1 year at the market)

generally, the profit is 1000% per product unit

payback period: 15 months

broad distribution area

ecologically friendly production

Product uniqueness and

competitive advantages

Investment advantages

Product Uniqueness

PharmaSapphire

Other world markets – 38%

Key Competitors’ Market

Major Distribution Area

RUSSIA

30% of total world production of

pharmaceuticals

25% 7%

PharmaSapphire

Project Team

Vitali Savenkov – project initiator,

patent holder.Experienced in

managing industrial processes and

supervising more than 100 employees.

The project scientific staff is represented by five Doctors of Biological Sciences, Pharmacy,

Chemistry , Physical and Mathematical Sciences. They all are professors, some of

them are of world-wide reputation. They are known for their numerous scientific

achievements and as the authors of many well-known scientific works and patents. They

received a lot of national awards for their scientific and technical breakthroughs. The

Company’s Sales Director has a long experience and knows techniques on how to

sell manufacturing equipment. He was engaged in and knows how to create a dealership network from zero cycle.

The Project Design Manager was one of the originators who were preparing design-engineering documentation for sapphire

dosing pumps. Currently, the Company has preliminary orders for 1,000 sapphire dosing

pumps from large Russian pharmaceutical companies, which is around 7 million US

dollars.

PharmaSapphire

The Company holds two Russian patents, there were filed new applications for Russian and international patents.

Project Needs

The Project needs investments of $5.5 mln. USD

PharmaSapphire

Investment Expenditures Pie Chart

Equipment $2.5mln. USD

R&D $1 mln.USD

Marketing $0.8mln. USD

Other $1.2 mln.USD

Thank you for your attention!

PharmaSapphire

Vitali Savenkov, General Director,

+7 (909) 676-5128,sapf@inbox.ru

www.sapptech.ru

Skolkovo Investment Office

Eduard Kanalosh+7 (495) 967-0148,ekanalosh@sk.ru

www.sk.ru